MicroRNA-21 inhibits toll-like receptor 2 agonistinduced lung inflammation in mice

Experimental Lung Research

Volumn 37, Issue 8, 2011, Pages 500-508

  Case, Stephanie R ^a   Martin, Richard J ^a   Jiang, Di ^a   Minor, Maisha N ^a   Chu, Hong Wei ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

Airway epithelial cells; Lung; Mice; MicroRNA; Toll like receptor 2

Indexed keywords

KERATINOCYTE DERIVED CHEMOKINE; MICRORNA 21; TOLL LIKE RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY EPITHELIUM; SIGNAL TRANSDUCTION; TH2 CELL; UPREGULATION;

ANIMALS; EPITHELIAL CELLS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-13; LIPOPEPTIDES; MICE; MICE, INBRED BALB C; MICRORNAS; PNEUMONIA; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; UP-REGULATION;

EID: 80052741610     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2011.596895     Document Type: Article

References (35)

1. Martin RJ: Infections and asthma. Clin Chest Med. 2006;27:87-98, vi.
2. Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH: A link between chronic asthma and chronic infection. J Allergy Clin Immunol. 2001;107:595-601. (Pubitemid 32397743)
3. Kraft M, Cassell GH, Henson JE, Watson H, Williamson J, Marmion BP, Gaydos CA,Martin RJ: Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med. 1998;158:998-1001. (Pubitemid 28449473)
4. Baseman JB, Tully JG: Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis. 1997;3:21-32. (Pubitemid 127433636)
5. Wu Q, Martin RJ, LaFasto S, Chu HW: A low dose of Mycoplasma pneumoniae infection enhances an established allergic inflammation in mice: the role of the prostaglandin E2 pathway. Clin Exp Allergy. 2009;39:1754-1763.
6. Green RM,Gally F, Keeney JG, Alper S, Gao B,Han M, Martin RJ, Weinberger AR, Case SR, Minor MN, Chu HW: Impact of cigarette smoke exposure on innate immunity: a Caenorhabditis elegans model. PLoS One. 2009;4:e6860.
7. Brunetti L, Colazzo D, Francavilla R, Tesse R, De Sario V, Lore M, Armenio L: The role of pulmonary infection in pediatric asthma. Allergy Asthma Proc. 2007;28:190-193.
8. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA: Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002;57:759-764. (Pubitemid 34984972)
9. Gualano RC, Vlahos R, Anderson GP:What is the contribution of respiratory viruses and lung proteases to airway remodelling in asthma and chronic obstructive pulmonary disease? Pulm Pharmacol Ther. 2006;19:18-23. (Pubitemid 41606848)
10. Kayembe JM, Louis R, Corhay JL, Bury T, Agnan R, Weber T, Duysinx B, Radermecker M: Usefulness of induced sputum analysis in pulmonary diseases. Acta Clin Belg. 1997;52:106-111. (Pubitemid 27293451)
11. Wu Q, Martin RJ, Lafasto S, Efaw BJ, Rino JG, Harbeck RJ, Chu HW: Toll-like receptor 2 down-regulation in established mouse allergic lungs contributes to decreased mycoplasma clearance. Am J Respir Crit Care Med. 2008;177:720-729. (Pubitemid 351490559)
12. Sioud M: Promises and challenges in developing RNAi as a research tool and therapy. Methods Mol Biol. 2011;703:173-187.
13. Kuttenkeuler D, Pelte N, Ragab A, Gesellchen V, Schneider L, Blass C, Axelsson E, Huber W, Boutros M: A large-scale RNAi screen identifies Deaf1 as a regulator of innate immune responses in Drosophila. J Innate Immun. 2010;2:181-194.
14. Mueller S, Gausson V, Vodovar N, Deddouche S, Troxler L, Perot J, Pfeffer S, Hoffmann JA, Saleh MC, Imler JL: RNAi-mediated immunity provides strong protection against the negative-strand RNA vesicular stomatitis virus in Drosophila. Proc Natl Acad Sci U S A. 2010;107:19390-19395.
15. Valanne S, Myllymaki H, Kallio J, Schmid MR, Kleino A, Murumagi A, Airaksinen L, Kotipelto T, Kaustio M, Ulvila J, Esfahani SS, Engstrom Y, Silvennoinen O, Hultmark D, Parikka M, Ramet M: Genome-wide RNA interference in Drosophila cells identifies G protein-coupled receptor kinase 2 as a conserved regulator of NF-kappaB signaling. J Immunol. 2010;184:6188-6198.
16. Sasaki K, Kohanbash G, Hoji A, Ueda R,McDonald HA, Reinhart TA, Martinson J, Lotze MT, Marincola FM, Wang E, Fujita M, Okada H: miR-17-92 expression in differentiated T cells-implications for cancer immunotherapy. J Transl Med. 2010;8:17-28.
17. Elmen J, Lindow M, Silahtaroglu A, Bak M, Christensen M, Lind-Thomsen A, Hedtjarn M, Hansen JB, Hansen HF, Straarup EM, McCullagh K, Kearney P, Kauppinen S: Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 2008;36:1153-1162. (Pubitemid 351330933)
18. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, O'Neill LA: Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2010;11:141-147.
19. Kuhn AR, Schlauch K, Lao R, Halayko AJ, Gerthoffer WT, Singer CA: MicroRNA expression in human airway smooth muscle cells: role of miR-25 in regulation of airway smooth muscle phenotype. Am J Respir Cell Mol Biol. 2010;42:506-513.
20. Moschos SA, Williams AE, Perry MM, BirrellMA, Belvisi MG, Lindsay MA: Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharideinduced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics. 2007;8:240.
21. O'Neill LA, Sheedy FJ, McCoy CE: MicroRNAs: the finetuners of Toll-like receptor signalling. Nat Rev Immunol. 2011;11:163-175.
22. Lu TX, Munitz A, Rothenberg ME: MicroRNA-21 is upregulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol. 2009;182:4994-5002.
23. Bergsson G, Reeves EP, McNally P, Chotirmall SH, Greene CM, Greally P, Murphy P, O'Neill SJ, McElvaney NG: LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline. J Immunol. 2009;183:543-551.
24. Chu HW, Thaikoottathil J, Rino JG, Zhang G, Wu Q, Moss T, Refaeli Y, Bowler R, Wenzel SE, Chen Z, Zdunek J, Breed R, Young R, Allaire E, Martin RJ: Function and regulation of SPLUNC1 protein in Mycoplasma infection and allergic inflammation. J Immunol. 2007;179:3995-4002.
25. Benakanakere MR, Li Q, Eskan MA, Singh AV, Zhao J, Galicia JC, Stathopoulou P, Knudsen TB, Kinane DF: Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem. 2009;284:23107-23115.
26. Selcuklu SD, Donoghue MT, Spillane C: miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans. 2009;37(Pt 4):918-925.
27. Fluiter K, ten Asbroek AL, de Wissel MB, Jakobs ME, Wissenbach M, Olsson H, Olsen O, Oerum H, Baas F: In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides. Nucleic Acids Res. 2003;31:953-962. (Pubitemid 36240433)
28. Wu Q, Jiang D, Minor MN, Martin RJ, Chu HW: In vivo function of airway epithelial TLR2 in host defense against bacterial infection. Am J Physiol Lung Cell Mol Physiol. 2011;300:L579-L586.
29. Chu HW, Jeyaseelan S, Rino JG, Voelker DR, Wexler RB, Campbell K, Harbeck RJ, Martin RJ: TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. J Immunol. 2005;174:5713-5719. (Pubitemid 40593214)
30. Koller B, Kappler M, Latzin P, Gaggar A, Schreiner M, Takyar S, Kormann M, Kabesch M, Roos D, Griese M, Hartl D: TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. J Immunol. 2008;181:2753-2763.
31. Ma WJ, Lv GD, Tuersun A, Liu Q, Liu H, Zheng ST, Huang CG, Feng JG, Wang X, Lin RY, Sheyhidin I, Lu XM: Role of microRNA-21 and effect on PTEN in Kazakh's esophageal squamous cell carcinoma. Mol Biol Rep. 2011;38:3253-3260.
32. Lou Y, Yang X, Wang F, Cui Z, Huang Y: MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med. 2010;26:819-827.
33. Bhatti I, Lee A, James V, Hall RI, Lund JN, Tufarelli C, Lobo DN, Larvin M: Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2011;15:199-208.
34. Reis PP, Tomenson M, Cervigne NK, Machado J, Jurisica I, Pintilie M, Sukhai MA, Perez-Ordonez B, Grenman R, Gilbert RW, Gullane PJ, Irish JC, Kamel-Reid S: Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol Cancer. 2010;9:238-240 .
35. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K: STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell. 2010;39:493-506